IntrinsicIntrinsic
← Scroll for more →

Financial Statements — SLGL

Balance Sheet

(in millions USD)
MetricQ4 2025Q2 2025Q4 2024Q2 2024Q4 2023Q2 2023Q4 2022Q2 2022Q4 2021Q2 2021
Cash & Equivalents11.0310.2219.4911.557.5115.6212.455.7720.0911.15
Short-term Investments12.9714.054.4314.9120.4717.868.689.851.716.83
Accounts Receivable1.9710.043.606.060.382.217.8610.1813.070.96
Total Current Assets26.9736.2631.3038.2841.1751.5943.0648.4857.1141.39
Property, Plant & Equipment0.140.160.200.310.430.570.660.831.051.40
Total Non-current Assets2.953.054.553.724.123.513.576.5112.085.01
Total Assets29.9239.3135.8542.0145.2955.1046.6354.9869.1946.41
Accounts Payable--1.17--0.68--0.46--0.860.771.35
Total Current Liabilities6.174.965.295.204.525.673.333.2311.695.16
Total Non-current Liabilities0.942.471.711.902.121.141.091.411.902.00
Total Liabilities7.117.437.007.106.646.814.424.6313.607.16
Retained Earnings(237.01)(228.08)(230.88)(224.67)(220.30)(209.76)(193.06)(183.87)(178.14)(193.46)
Total Stockholder Equity22.8131.8828.8534.9038.6448.3042.2150.3555.5939.25
← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Total Revenue17.265.430.593.520.90
Research & Development4.652.445.312.386.93
Selling, General & Admin1.391.371.811.602.04
Operating Income11.231.62(6.53)(0.46)(8.04)
Net Income11.611.98(5.97)(0.13)(8.03)
Basic EPS4.170.070.220.01--
Diluted EPS4.170.070.220.01--
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Operating Cash Flow0.60(7.63)(8.34)(6.54)(11.37)
Capital Expenditures0.030.000.090.100.05
Free Cash Flow*0.57(7.63)(8.43)(6.65)(11.42)
Investing Cash Flow(9.81)12.47(10.20)(7.92)15.33
Financing Cash Flow0.000.0021.720.020.08
← Scroll for more columns →

* Derived from reported values